ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

PEDVAXHIB
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

PEDVAXHIB Rx

Generic Name and Formulations:
Haemophilus b conjugate 7.5mcg (meningococcal protein conjugate 250mcg); per 0.5mL; IM inj.

Company:
Merck & Co., Inc.

Therapeutic Use:

Indications for PEDVAXHIB:

Immunization of children against H. influenzae type b.

Children:

<2 months: not recommended. 2 and 4 months: 0.5mL lM. Children vaccinated (with 2 dose regimen) before 12 months should receive booster at 12 months (but not <2 months after previous shot). Previously unvaccinated children, 15–71 months: 0.5mL lM once.

Contraindications:

Aluminum allergy.

Warnings/Precautions:

Immunodeficiency. Delay administration in febrile or active infection. Have epinephrine inj (1:1000) available. Protection begins several days after injection. Pregnancy (Cat. C): not recommended.

Pharmacological Class:

Hib (PRP-OMP).

Adverse Reactions:

Local reactions, fever.

How Supplied:

Single-dose vials (w. diluent)—10

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs